KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $43,000 | -47.6% | 6,000 | -47.1% | 0.00% | -33.3% |
| Q2 2017 | $82,000 | +121.6% | 11,335 | +88.9% | 0.00% | +50.0% |
| Q1 2017 | $37,000 | +5.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $35,000 | +9.4% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $32,000 | -20.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | +33.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $30,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |